Related references
Note: Only part of the references are listed.P-glycoprotein (ABCB1) activity decreases raltegravir disposition in primary CD4+P-gphigh cells and correlates with HIV-1 viral load
Gerard Minuesa et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2016)
Inhibition of Human Efflux Transporter ABCC2 (MRP2) by Self-emulsifying Drug Delivery System: Influences of Concentration and Combination of Excipients
Liang Li et al.
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES (2014)
Role of P-glycoprotein in the efflux of raltegravir from human intestinal cells and CD4+T-cells as an interaction target for anti-HIV agents
Yumi Hashiguchi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Interactions between human multidrug resistance related protein (MRP2; ABCC2) and excipients commonly used in self-emulsifying drug delivery systems (SEDDS)
Liang Li et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2013)
A high throughput in vitro mrp2 assay to predict in vivo biliary excretion
Federico Colombo et al.
XENOBIOTICA (2012)
Effects of cytochrome P450 3A (CYP3A) and the drug transporters P-glycoprotein (MDR1/ABCB1) and MRP2 (ABCC2) on the pharmacokinetics of lopinavir
R. A. B. van Waterschoot et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Commonly used nonionic surfactants interact differently with the human efflux transporters ABCB1 (p-glycoprotein) and ABCC2 (MRP2)
Ulrike Hanke et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
MRP2 mediated drug-drug interaction: Indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting
Arik Dahan et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2010)
A Caco-2 cell based screening method for compounds interacting with MRP2 efflux protein
Sanna Siissalo et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2009)
Compound profiling for ABCC2 (MRP2) using a fluorescent microplate assay system
Frank Foerster et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2008)
Pluronic block copolymers: Evolution of drug delivery concept from inert nanocarriers to biological response modifiers
Elena V. Batrakova et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Characterization of 5(6)-carboxy-2,′7′-dichlorofluorescein transport by MRP2 and utilization of this substrate as a fluorescent surrogate for LTC4
Krisztina Heredi-Szabo et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
Both P-gp and MRP2 mediate transport of Lopinavir, a protease inhibitor
Sheetal Agarwal et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2007)
Interaction of nonsteroidal anti-inflammatory drugs with multidrug resistance protein (MRP) 2/ABCC2-and MRP4/ABCC4-mediated methotrexate transport
Azza A. K. El-Sheikh et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
A kinetic study of Rhodamine123 pumping by P-glycoprotein
Yulin Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2006)
In vitro P-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: A recommendation for probe substrates
J Rautio et al.
DRUG METABOLISM AND DISPOSITION (2006)
Intestinal fluid volumes and transit of dosage forms as assessed by magnetic resonance imaging
C Schiller et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2005)
Assessment of drug interactions in hepatobiliary transport using rhodamine 123 in sandwich-cultured rat hepatocytes
PP Annaert et al.
DRUG METABOLISM AND DISPOSITION (2005)
Differential multidrug resistance-associated protein 1 through 6 isoform expression and function in human intestinal epithelial Caco-2 cells
HM Prime-Chapman et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2004)
Relationships between the hydrophilic-lipophilic balance values of pharmaceutical excipients and their multidrug resistance modulating effect in Caco-2 cells and rat intestines
YI Lo
JOURNAL OF CONTROLLED RELEASE (2003)
The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins
K Bogman et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2003)
Optimal structure requirements for pluronic block copolymers in modifying P-glycoprotein drug efflux transporter activity in bovine brain microvessel endothelial cells
EV Batrakova et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Fexofenadine transport in Caco-2 cells: Inhibition with verapamil and ritonavir
MD Perloff et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2002)
Effects of poly(ethylene glycol) on efflux transporter activity in Caco-2 cell monolayers
ED Hugger et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Active transport of fluorescent P-glycoprotein substrates: Evaluation as markers and interaction with inhibitors
EJ Wang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2001)
Rhodamine 123 binds to multiple sites in the multidrug resistance protein (MRP1)
R Daoud et al.
BIOCHEMISTRY (2000)
Inhibitory effect of the reversal agents V-104, GF120918 and pluronic L61 on MDR1 Pgp-, MRP1- and MRP2-mediated transport
R Evers et al.
BRITISH JOURNAL OF CANCER (2000)
Share Paper
